| Home > Publications Database > Molecular-level interplay between intrinsically disordered clients and Hsp90. > print |
| 001 | 257684 | ||
| 005 | 20250411153447.0 | ||
| 024 | 7 | _ | |a 10.1016/j.cbpa.2023.102304 |2 doi |
| 024 | 7 | _ | |a pmid:37068388 |2 pmid |
| 024 | 7 | _ | |a 1367-5931 |2 ISSN |
| 024 | 7 | _ | |a 1879-0402 |2 ISSN |
| 024 | 7 | _ | |a altmetric:146024470 |2 altmetric |
| 037 | _ | _ | |a DZNE-2023-00481 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Ramirez, Lisa Marie |0 P:(DE-2719)9001275 |b 0 |e First author |u dzne |
| 245 | _ | _ | |a Molecular-level interplay between intrinsically disordered clients and Hsp90. |
| 260 | _ | _ | |a London |c 2023 |b Current Biology Ltd. |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1744378448_5312 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Proteostasis is maintained by a network of molecular chaperones, a prominent member of which is the 90-kilodalton heat shock protein Hsp90. The chaperone function of Hsp90 has been extensively reviewed previously, emphasizing its ATPase activity and remodeling of folded client proteins. Experimental evidence implicating Hsp90 in neurodegenerative diseases has bolstered interest in the noncanonical chaperoning of intrinsically disordered protein (IDPs), however the interplay between Hsp90 and its disordered clients remains poorly understood. In this review we describe recent advances that have contributed to our understanding of the intricate mechanisms characterizing Hsp90-mediated chaperoning of the IDPs tau and α-synuclein and survey emerging insights into the modulation of the chaperone-client interplay in the context of neurodegeneration. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a α-Synuclein |2 Other |
| 650 | _ | 7 | |a α-Synuclein |2 Other |
| 650 | _ | 7 | |a Alzheimer's disease |2 Other |
| 650 | _ | 7 | |a Heat shock protein |2 Other |
| 650 | _ | 7 | |a Hsp90 |2 Other |
| 650 | _ | 7 | |a Structure |2 Other |
| 650 | _ | 7 | |a Tau |2 Other |
| 650 | _ | 7 | |a α-Synuclein |2 Other |
| 650 | _ | 7 | |a HSP90 Heat-Shock Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a Molecular Chaperones |2 NLM Chemicals |
| 650 | _ | 7 | |a Intrinsically Disordered Proteins |2 NLM Chemicals |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a HSP90 Heat-Shock Proteins: metabolism |2 MeSH |
| 650 | _ | 2 | |a Molecular Chaperones |2 MeSH |
| 650 | _ | 2 | |a Proteostasis |2 MeSH |
| 650 | _ | 2 | |a Intrinsically Disordered Proteins: metabolism |2 MeSH |
| 650 | _ | 2 | |a Neurodegenerative Diseases |2 MeSH |
| 700 | 1 | _ | |a Zweckstetter, Markus |0 P:(DE-2719)2810591 |b 1 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1016/j.cbpa.2023.102304 |g Vol. 74, p. 102304 - |0 PERI:(DE-600)2019216-2 |p 102304 |t Current opinion in chemical biology |v 74 |y 2023 |x 1367-5931 |
| 856 | 4 | _ | |u https://www.sciencedirect.com/science/article/abs/pii/S136759312300042X?via%3Dihub |
| 856 | 4 | _ | |u https://pub.dzne.de/record/257684/files/DZNE-2023-00481_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/257684/files/DZNE-2023-00481_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:257684 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)9001275 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2810591 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-16 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-22 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |d 2023-10-22 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CURR OPIN CHEM BIOL : 2022 |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-22 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-22 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CURR OPIN CHEM BIOL : 2022 |d 2023-10-22 |
| 920 | 1 | _ | |0 I:(DE-2719)1410001 |k AG Zweckstetter |l Translational Structural Biology |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1410001 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|